These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11887818)

  • 21. Role of VEGF-flt receptor system in normal and tumor angiogenesis.
    Shibuya M
    Adv Cancer Res; 1995; 67():281-316. PubMed ID: 8571818
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum.
    Combet S; Ferrier ML; Landschoot MV; Stoenoiu M; Moulin P; Miyata T; Lameire N; Devuyst O
    J Am Soc Nephrol; 2001 Oct; 12(10):2146-2157. PubMed ID: 11562414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor.
    Ferrara N
    Eur J Cancer; 1996 Dec; 32A(14):2413-22. PubMed ID: 9059329
    [No Abstract]   [Full Text] [Related]  

  • 24. High glucose dialysis solutions increase synthesis of vascular endothelial growth factors by peritoneal vascular endothelial cells.
    Seo MJ; Oh SJ; Kim SI; Cho KW; Jo I; Schaub T; Schilling H; Passlick-Deetjen J; Han DC
    Perit Dial Int; 2001; 21 Suppl 3():S35-40. PubMed ID: 11887852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of nitric oxide in the angiogenesis of avascular tissue.
    Ziche M
    Osteoarthritis Cartilage; 1999 Jul; 7(4):403-5. PubMed ID: 10419781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.
    Kihm LP; Müller-Krebs S; Klein J; Ehrlich G; Mertes L; Gross ML; Adaikalakoteswari A; Thornalley PJ; Hammes HP; Nawroth PP; Zeier M; Schwenger V
    J Am Soc Nephrol; 2011 May; 22(5):914-26. PubMed ID: 21511829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular permeability factor/vascular endothelial growth factor and vascular stroma formation in neoplasia. Insights from in situ hybridization studies.
    Brown LF; Guidi AJ; Tognazzi K; Dvorak HF
    J Histochem Cytochem; 1998 May; 46(5):569-75. PubMed ID: 9562567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
    Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
    Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoangiogenesis in the peritoneal membrane.
    Krediet RT; Zweers MM; van der Wal AC; Struijk DG
    Perit Dial Int; 2000; 20 Suppl 2():S19-25. PubMed ID: 10911638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution.
    Günal AI; Celiker H; Akpolat N; Ustündag B; Duman S; Akcicek F
    Perit Dial Int; 2002; 22(3):301-6. PubMed ID: 12227386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth factor control of developing kidney endothelial cells.
    Loughna S; Landels E; Woolf AS
    Exp Nephrol; 1996; 4(2):112-8. PubMed ID: 8673440
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiogenic growth factors in neural embryogenesis and neoplasia.
    Zagzag D
    Am J Pathol; 1995 Feb; 146(2):293-309. PubMed ID: 7531952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor--its role in retinal vascular proliferation.
    Frank RN
    N Engl J Med; 1994 Dec; 331(22):1519-20. PubMed ID: 7526213
    [No Abstract]   [Full Text] [Related]  

  • 34. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.
    Fukumura D; Gohongi T; Kadambi A; Izumi Y; Ang J; Yun CO; Buerk DG; Huang PL; Jain RK
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2604-9. PubMed ID: 11226286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Angioneogenesis--the key etiology in many cases of blindness].
    Richard G; Meyer-Bothling U
    Klin Monbl Augenheilkd; 1996 Apr; 208(4):III-IV. PubMed ID: 8778486
    [No Abstract]   [Full Text] [Related]  

  • 36. Peritoneal dialysis in diabetic patients.
    Lee HB; Chung SH; Chu WS; Kim JK; Ha H
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S200-3. PubMed ID: 11576955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glucose metabolism in vascular endothelial cells].
    Yokota C; Okuda Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():324-30. PubMed ID: 12238067
    [No Abstract]   [Full Text] [Related]  

  • 38. Interesting news in peritoneal dialysis.
    De Vriese AS
    Nephron; 2002 Dec; 92(4):763-71. PubMed ID: 12399619
    [No Abstract]   [Full Text] [Related]  

  • 39. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.
    Miller JW; Adamis AP; Aiello LP
    Diabetes Metab Rev; 1997 Mar; 13(1):37-50. PubMed ID: 9134347
    [No Abstract]   [Full Text] [Related]  

  • 40. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS
    J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.